Is Runny Nose a Side Effect of Ozempic?

Last reviewed: June 27, 2026

Last updated: June 27, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide medications like Ozempic work by activating GLP-1 receptors throughout the body, triggering appetite suppression and improved blood sugar control. While nausea, vomiting, and constipation are well-documented side effects, patients often wonder whether respiratory symptoms like runny nose occur with these medications.

Do GLP-1 Medications Cause Runny Nose or Nasal Congestion?

Clinical trials for semaglutide and other GLP-1 receptor agonists have not identified runny nose as a primary side effect. The Novo Nordisk trials that led to Ozempic's approval recorded gastrointestinal symptoms in 40–60% of participants, while respiratory complaints remained minimal and sporadic. Runny nose does not appear in the standard adverse event profile for this drug class.

Some patients report experiencing nasal symptoms coincidentally while taking semaglutide, but temporal association does not prove causation. Cold viruses, seasonal allergies, and environmental irritants remain far more likely culprits. If a runny nose develops shortly after starting a GLP-1 medication, consider whether you've been exposed to sick contacts, changing weather, or allergens in your environment before attributing it to the drug.

Why GLP-1 Side Effects Focus on the Digestive System

GLP-1 receptors are concentrated in the gastrointestinal tract, pancreas, and brain regions controlling appetite and satiety. When semaglutide activates these receptors, the stomach empties more slowly, meal satisfaction increases, and appetite signals diminish. This mechanism explains why nausea, vomiting, diarrhea, and constipation dominate the side effect profile rather than nasal or respiratory changes.

The vagus nerve, which carries GLP-1 signals from the brain to the gut, plays a central role in this digestive cascade. Respiratory tissues like nasal membranes lack the high density of GLP-1 receptors found in the alimentary system, so direct drug effects on the nose are biochemically unlikely. Most users tolerate semaglutide well once the digestive adjustment period passes, typically within 2–4 weeks.

Common GLP-1 Side Effects You Are More Likely to Experience

Nausea ranks as the most frequent side effect, affecting 25–40% of semaglutide users during the first weeks of therapy. Constipation and diarrhea each occur in 15–30% of patients depending on dose and individual gut sensitivity. Vomiting, abdominal pain, and decreased appetite occur less often but remain clinically significant in some individuals.

These gastrointestinal effects usually improve as the body adapts to the medication. Staying hydrated, eating smaller frequent meals, and gradually increasing your dose as prescribed can reduce symptom severity. If digestive side effects persist beyond four weeks or become intolerable, discussing alternative GLP-1 compounds or dosing schedules with your healthcare provider becomes important.

When to Seek Medical Attention for Nasal or Other Symptoms

If you develop a persistent runny nose, severe congestion, or postnasal drip while on semaglutide, evaluate whether a cold, flu, or allergy is responsible before assuming medication involvement. A runny nose lasting more than two weeks, especially with fever or colored mucus, warrants evaluation by a primary care doctor to rule out infection or sinusitis.

Report any new or worsening respiratory symptoms to your prescriber, who can review your medication history and clinical context. PlexusDx partners with licensed 503A compounding pharmacies to dispense semaglutide across all 50 states, and your treatment team remains available to address concerns about side effects or symptom management. The Precision Peptide Genetic Test can identify individual peptide-pathway sensitivities that might influence how your body responds to GLP-1 therapy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is runny nose listed as a side effect of semaglutide in clinical trials?

No. Runny nose does not appear as a documented adverse event in Novo Nordisk's semaglutide trials or regulatory filings. Gastrointestinal symptoms dominate the side effect profile because GLP-1 receptors are concentrated in the digestive tract and brain appetite centers, not respiratory tissues.

Could a runny nose still be caused by my semaglutide dose?

While unlikely based on the drug's mechanism and clinical evidence, individual reactions vary. If a runny nose began immediately after starting semaglutide and resolved after stopping it, discuss this pattern with your prescriber. Consider whether environmental or infectious causes are more probable before attributing respiratory symptoms to the medication.

What are the most common side effects of GLP-1 therapy I should expect?

Nausea, vomiting, constipation, and diarrhea affect 15–60% of users depending on dose and individual tolerance. These effects typically peak during the first two to four weeks and improve with continued use. Most patients find side effects manageable through dietary adjustments, hydration, and gradual dose escalation.

How much does PlexusDx semaglutide cost per month?

PlexusDx compounded semaglutide injection starts at $149 per month with no insurance required, no membership fee, and HSA/FSA eligibility. Your dose may need to go up. Your price won't. All medications come from licensed 503A compounding pharmacies and are available in all 50 states.

Can the Precision Peptide Genetic Test help predict my side effects?

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 14 pathways and 49 peptides to map your genetic sensitivities across 150+ insights. This peptide-pathway analysis can reveal how your unique genetics influence GLP-1 receptor sensitivity and overall response to therapy, helping your provider personalize your treatment.

Related Reading

• Ozempic Side Effects
• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.